Australia markets closed

BioNxt Solutions Inc (BXT.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.1995-0.0345 (-14.74%)
At close: 07:26PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
372.247
372.247
297.442
286.498
345.654
Cost of revenue
0
0
101.827
87.02
0
Gross profit
372.247
372.247
195.615
199.478
345.654
Operating expenses
Research development
2,554
2,554
2,111
3,343
3,242
Selling general and administrative
3,518
3,518
3,427
11,713
10,372
Total operating expenses
6,759
6,759
6,241
16,510
15,149
Operating income or loss
-6,387
-6,387
-6,045
-16,310
-14,804
Interest expense
1,043
1,043
1,143
731.865
297.077
Total other income/expenses net
-293.144
-293.144
-5,682
-3,706
-2,146
Income before tax
-7,723
-7,723
-12,870
-20,748
-17,247
Income tax expense
0
0
-493.914
-110.739
-357.489
Income from continuing operations
-7,723
-7,723
-12,376
-20,637
-16,890
Net income
-7,723
-7,723
-12,376
-20,637
-16,890
Net income available to common shareholders
-7,723
-7,723
-12,376
-20,637
-16,890
Basic EPS
-0.14
-
-0.15
-0.29
-0.30
Diluted EPS
-0.14
-
-0.15
-0.29
-0.30
Basic average shares
95,757
-
83,774
70,235
57,217
Diluted average shares
95,757
-
83,774
70,235
57,217